title: Previous burn injury predisposes mice to lipopolysaccharide-induced changes in glucose metabolism.
abstract: In mice, it has been demonstrated that at 7 days after burn injury, injection of lipopolysaccharide (LPS) is more lethal than the same dose at 1 day after injury. In the present study, we examined the effect of LPS injection to mice burned 7 days previously on glucose metabolism ([(18)F] 2-fluoro-2-deoxy-D-glucose [(18)FDG] uptake) in vivo. CD-1 male mice (25-28 g, Charles River Breeding Laboratories, Wilmington, MA) were anesthetized, backs shaven, and subjected to dorsal full thickness burn on 25% TBSA. Sham-treated animals were used as controls. Six days after burn injury, all mice were fasted overnight. One half of the burned and sham controls were subsequently injected IP with LPS (10 mg/kg; Escherichia coli). The remaining animals were injected with saline IP. Two hours later, all mice were injected IV with 50 μCi of (18)F FDG. One hour later, the animals were euthanized, and biodistribution was measured. Tissues were weighed, and radioactivity was measured with a well-type γ counter. Results were expressed as %dose/g tissue, mean ± SEM. The combination of burn 7 days previously and LPS significantly increased mortality compared to animals with burn alone, LPS alone, or sham controls. Burn injury 7 days previously caused a significant decrease in (18)FDG uptake by the brain compared to sham controls. The combination of LPS and burn injury 7 days previously produced a significant increase in (18)FDG uptake by brown adipose tissue and heart compared with either treatment separately. LPS produced a significant increase in (18)FDG uptake by lung, spleen, and gastrointestinal tract of the sham animals, changes that were different in mice burned 7 days previously and injected with LPS. The present results suggest that burn injury 7 days previously predisposes mice to alterations in (18)FDG uptake produced by LPS. These changes may relate, in part, to the increased lethality of LPS injection in previously burned mice.
authors.affiliation: Department of Pediatrics, Massachusetts General Hospital, Boston 02129, USA.
authors.forename: Edward A
authors.initials: EA
authors.lastname: Carter
authors.forename: Kasie W
authors.initials: KW
authors.lastname: Paul
authors.forename: Sandra A
authors.initials: SA
authors.lastname: Barrow
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Fischman
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Tompkins
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D002056:Burns / Q000150:complications* / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D019788:Fluorodeoxyglucose F18 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000009:adverse effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D019275:Radiopharmaceuticals / Q000378:metabolism; D012307:Risk Factors; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D008070:Lipopolysaccharides; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18